Reply: To PMID 24440221.

Regueiro, Miguel; Kip, Kevin E; Baidoo, Leonard; Swoger, Jason M; Schraut, Wolfgang

Regueiro, Miguel; Kip, Kevin E; Baidoo, Leonard; Swoger, Jason M; Schraut, Wolfgang.

Afiliação

Regueiro M; Inflammatory Bowel Disease Center, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Kip KE; Research Center, College of Nursing, University of South Florida, Tampa, Florida.
Baidoo L; Inflammatory Bowel Disease Center, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Swoger JM; Inflammatory Bowel Disease Center, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Schraut W; Division of Gastrointestinal Surgery, Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Clin Gastroenterol Hepatol ; 12(10): 1764-5, 2014 Oct.

Article em En | MEDLINE | ID: mdl-24956081

Assuntos

Anticorpos Monoclonais/uso terapêutico; Doença de Crohn/tratamento farmacológico; Doença de Crohn/cirurgia; Fatores Imunológicos/uso terapêutico; Cuidados Pós-Operatórios/métodos; Feminino; Humanos; Infliximab; Masculino

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cuidados Pós-Operatórios / Doença de Crohn / Fatores Imunológicos / Anticorpos Monoclonais Limite: Female / Humans / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google